Global Leadership

Go Further

Saving women's lives from cervical cancer in sub-Saharan Africa.

4.4M

Cervical cancer screenings supported for women living with HIV

3.7M

Women screened for the first time

7.1M

Women living with HIV in the twelve Go Further target countries

Accelerating Access to Treatment for Advanced Cervical Cancer
Report
Go Further: A Partnership that is Going Further for Women
Report
Go Further: Fact Sheets
Report
8

Jabu's Story: Living with HIV, Surviving Cervical Cancer
Article • January 9, 2020
1

A Partnership That Goes Further For Women
Article • July 1, 2020
10

Surviving Cervical Cancer
Article • September 26, 2019
An Oral History of PEPFAR: How a "Dream Big" Partnership is Saving the Lives of Millions

Posted on: December 1, 2018 / Updated: December 14, 2018
Report
George W. Bush: PEPFAR saves millions of lives in Africa. Keep it fully funded.

Washington Post • April 7, 2017
7

President and Mrs. Bush's Visit to Namibia and Botswana in Photos

They delivered a message to Congress and all Americans: lives in Africa matter.
Article • April 13, 2017

The Go Further partnership is implementing a strategy to end cervical cancer and save lives. Women living with HIV are six times more likely to develop cervical cancer.

Launched in May 2018, Go Further is an innovative public-private partnership between the U.S. President Emergency Plan for AIDS Relief, the George W. Bush Institute, UNAIDS, Merck, and Roche.

Go Further is committed to creating a healthier future for women. The partnership aims to reduce new cervical cancer cases by 95 percent among women living with HIV in twelve African countries, which have some of the highest rates of HIV prevalence and cervical cancer incidence in the world.

Go Further invests in partner countries to integrate and scale-up cervical cancer screening and treatment services within existing platforms for HIV treatment and women’s health.

The Bush Institute and PEPFAR have partnered in this space since 2011, and since Go Further was launched in 2018, PEPFAR has invested over $168 million in cervical cancer screening and treatment for HIV-positive women.

The success of this program is made possible by the thousands of mothers, sisters, and daughters who bravely confront HIV and cervical cancer diagnoses every day.

Through this partnership

More than 4.4 million cervical cancer screenings for women living with HIV have been completed
Over 3.7 million women living with HIV have been screened for the first time
More than 169,000 treatments for precancerous lesions have been performed